2 tracked superinvestors hold MODERNA INC (MRNA), worth $726M combined, led by Overdeck / Siegel. Smart money is accumulating MRNA as of the latest 13F filings.
Current price
$76.56
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3…
Market cap
$18.0B
P/E
-6.25
Div yield
0.0%
Revenue YoY
-39.2%
Analyst target
$45
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$726M
disclosed long exposure
Tier-1 conviction
0
concentrated holders
Net this quarter
+2
2 buying · 0 selling
Smart money is net accumulating MRNA: 2 funds added or opened versus 0 trimming.
MODERNA INC (MRNA) appears mainly in diversified and quant books here (2 funds, $726M combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.
The largest position belongs to Overdeck / Siegel at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 2 added and 0 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Added | 0.4% | $468M | |
| Added | 0.4% | $258M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own MRNA?
2 tracked funds hold MODERNA INC (MRNA), the largest being Overdeck / Siegel (Two Sigma) at 0.4% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling MRNA?
In the most recent 13F quarter, 2 tracked funds added or opened MRNA and 0 trimmed it.
How much MRNA do tracked funds hold?
Combined disclosed long exposure to MRNA across tracked superinvestors is $726M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.